S

Cassava Sciences

D
SAVA
USD
1.39
(5.8135%)
Market Closed
32,089.00
Volume
-3.88
EPS
-
Div Yield
-8.968198
P/E
1,213,796,999.80
Market Cap
Today
-4.9230%
1 Week
-1.938%
1 Month
-0.511%
6 Months
15.949%
12 Months
13.453%
Year To Date
12.394%
All Time
0%

Title:
Cassava Sciences

Sector:
Healthcare
Industry:
Biotechnology
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Do you need help or have a question?